These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 27853939)

  • 1. Wharton's Jelly Mesenchymal Stromal Cells as a Feeder Layer for the Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells: a Review.
    Lo Iacono M; Anzalone R; La Rocca G; Baiamonte E; Maggio A; Acuto S
    Stem Cell Rev Rep; 2017 Feb; 13(1):35-49. PubMed ID: 27853939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells.
    Li Q; Zhao D; Chen Q; Luo M; Huang J; Yang C; Wang F; Li W; Liu T
    Stem Cell Res Ther; 2019 Dec; 10(1):376. PubMed ID: 31806004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wharton's Jelly Mesenchymal Stromal Cells Support the Expansion of Cord Blood-derived CD34
    Lo Iacono M; Russo E; Anzalone R; Baiamonte E; Alberti G; Gerbino A; Maggio A; La Rocca G; Acuto S
    Cell Transplant; 2018 Jan; 27(1):117-129. PubMed ID: 29562783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34
    Zhao D; Liu L; Chen Q; Wang F; Li Q; Zeng Q; Huang J; Luo M; Li W; Zheng Y; Liu T
    Stem Cell Res Ther; 2018 Jun; 9(1):158. PubMed ID: 29895317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of a novel embryonic stem cell cord blood-derived population with in vitro hematopoietic capacity in the presence of Wharton's jelly-derived mesenchymal stromal cells.
    Gounari E; Daniilidis A; Tsagias N; Michopoulou A; Kouzi K; Koliakos G
    Cytotherapy; 2019 Feb; 21(2):246-259. PubMed ID: 30522805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: biological properties and emerging clinical applications.
    Batsali AK; Kastrinaki MC; Papadaki HA; Pontikoglou C
    Curr Stem Cell Res Ther; 2013 Mar; 8(2):144-55. PubMed ID: 23279098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal Stromal Cells from Perinatal Tissues as an Alternative for Ex Vivo Expansion of Hematopoietic Progenitor and Stem Cells from Umbilical Cord Blood.
    Bonilla X; Lara AM; Llano-León M; López-González DA; Hernández-Mejía DG; Bustos RH; Camacho-Rodríguez B; Perdomo-Arciniegas AM
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells from the Wharton's jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem cells during long-term ex vivo culture.
    Bakhshi T; Zabriskie RC; Bodie S; Kidd S; Ramin S; Paganessi LA; Gregory SA; Fung HC; Christopherson KW
    Transfusion; 2008 Dec; 48(12):2638-44. PubMed ID: 18798803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.
    Cardoso TC; Ferrari HF; Garcia AF; Novais JB; Silva-Frade C; Ferrarezi MC; Andrade AL; Gameiro R
    BMC Biotechnol; 2012 May; 12():18. PubMed ID: 22559872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human umbilical cord Wharton's jelly stem cells and its conditioned medium support hematopoietic stem cell expansion ex vivo.
    Fong CY; Gauthaman K; Cheyyatraivendran S; Lin HD; Biswas A; Bongso A
    J Cell Biochem; 2012 Feb; 113(2):658-68. PubMed ID: 21976004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo expansion of hematopoietic stem- and progenitor cells from cord blood in coculture with mesenchymal stroma cells from amnion, chorion, Wharton's jelly, amniotic fluid, cord blood, and bone marrow.
    Klein C; Strobel J; Zingsem J; Richter RH; Goecke TW; Beckmann MW; Eckstein R; Weisbach V
    Tissue Eng Part A; 2013 Dec; 19(23-24):2577-85. PubMed ID: 24308543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.
    Liau LL; Ruszymah BHI; Ng MH; Law JX
    Curr Res Transl Med; 2020 Jan; 68(1):5-16. PubMed ID: 31543433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells.
    Jang YK; Jung DH; Jung MH; Kim DH; Yoo KH; Sung KW; Koo HH; Oh W; Yang YS; Yang SE
    Ann Hematol; 2006 Apr; 85(4):212-25. PubMed ID: 16391912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wharton's Jelly Mesenchymal Stromal Cells from Human Umbilical Cord: a Close-up on Immunomodulatory Molecules Featured In Situ and In Vitro.
    Corsello T; Amico G; Corrao S; Anzalone R; Timoneri F; Lo Iacono M; Russo E; Spatola GF; Uzzo ML; Giuffrè M; Caprnda M; Kubatka P; Kruzliak P; Conaldi PG; La Rocca G
    Stem Cell Rev Rep; 2019 Dec; 15(6):900-918. PubMed ID: 31741193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
    Devito L; Badraiq H; Galleu A; Taheem DK; Codognotto S; Siow R; Khalaf Y; Briley A; Shennan A; Poston L; McGrath J; Gentleman E; Dazzi F; Ilic D
    Regen Med; 2014; 9(6):723-32. PubMed ID: 25431909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cord blood CD34+ cells expanded on Wharton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice.
    Milazzo L; Vulcano F; Barca A; Macioce G; Paldino E; Rossi S; Ciccarelli C; Hassan HJ; Giampaolo A
    Eur J Haematol; 2014 Nov; 93(5):384-91. PubMed ID: 24797266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Wharton's jelly mesenchymal stem cells: properties, isolation and clinical applications.
    Borys-Wójcik S; Brązert M; Jankowski M; Ożegowska K; Chermuła B; Piotrowska-Kempisty H; Bukowska D; Antosik P; Pawelczyk L; Nowicki M; Jeseta M; Kempisty B
    J Biol Regul Homeost Agents; 2019 Jan-Feb,; 33(1):119-123. PubMed ID: 30729769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wharton's Jelly Derived-Mesenchymal Stem Cells: Isolation and Characterization.
    Ranjbaran H; Abediankenari S; Mohammadi M; Jafari N; Khalilian A; Rahmani Z; Momeninezhad Amiri M; Ebrahimi P
    Acta Med Iran; 2018 Jan; 56(1):28-33. PubMed ID: 29436792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment.
    De Bruyn C; Najar M; Raicevic G; Meuleman N; Pieters K; Stamatopoulos B; Delforge A; Bron D; Lagneaux L
    Stem Cells Dev; 2011 Mar; 20(3):547-57. PubMed ID: 20923277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.